28 Jan 2016

Private Placement of Convertible Bonds by QT Vascular Ltd. and its Subsidiary, Quattro Vascular Ptd. Ltd

Danny Lim and Caitlin Huang from the Capital Markets / Mergers & Acquisitions Practice Group acted for QT Vascular Ltd., which is listed on the Catalist Board of the Singapore Exchange, in an aggregate US$6.06 million private placement of convertible bonds by the company, and exchangeable bonds by the company's wholly-owned subsidiary, Quattro Vascular Ptd. Ltd.. The bonds proceeds will be applied for general working capital purposes as well as research and development.

The group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases, and its products are marketed in the United States as well as growing medical device markets, including Europe, PRC, Japan and other parts of Asia.